Akèy › Sipwa › Georgia › Johns Creek
Etid klinik pou Sipwa nan Johns Creek, GA
14 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Johns Creek (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Ap rekriteFaz 3
- Eastside Bariatric and Gen Surg, Snellville · 16 mi lwen
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Ap rekriteFaz 3
- Eastside Bariatric and Gen Surg, Snellville · 16 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- Teak Research Consults, Lawrenceville · 13 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Ap rekriteFaz 3
- Teak Research Consults, Lawrenceville · 13 mi lwen
- EBGS Clinical Research Center, Snellville · 16 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- Teak Research Consults, Lawrenceville · 13 mi lwen
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Ap rekriteFaz 2
- Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville · 13 mi lwen
- Physicians Research Associates, Lawrenceville · 13 mi lwen
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- Physicians Research Associates, Lawrenceville · 13 mi lwen
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, Lawrenceville · 13 mi lwen
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- Physicians Research Associates, Lawrenceville · 13 mi lwen
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Ap rekriteFaz 2
- Teak Research Consults, Lawrenceville · 13 mi lwen
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Lilburn · 10 mi lwen
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Lilburn · 10 mi lwen
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Nsc Research, Johns Creek
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Ap rekriteFaz 3
- ACCOMPLISH-1 Research Site, Buford · 13 mi lwen
- ACCOMPLISH-1 Research Site, Lawrenceville · 13 mi lwen
Etid Sipwa nan lòt vil
- San Antonio, TX34 etid
- Houston, TX33 etid
- Chicago, IL28 etid
- Orlando, FL27 etid
- Las Vegas, NV23 etid
- Miami, FL23 etid
- Atlanta, GA20 etid
- Dallas, TX20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
Lòt etid nan Johns Creek
- Obèsite16 etid
- Skizofreni8 etid
- Dyabèt Tip 28 etid
- Twoub depresif majè7 etid
- Kansè poumon6 etid
- Ensifizyans kadyak5 etid
- Kansè Poumon ki pa ti selil5 etid
- Hypertension artérielle4 etid
- Kansè nan tete4 etid
- Fibrilasyon atriyal4 etid
- Maladi ren kwonik3 etid
- Glomerulonefrit IGA3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.